• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Vacancies





























From a new persons perspective things seems to have been going downhill in 2021 based on the threads . Favoritism , selective promotion , and leadership shortcomings is a clear as day
Does Lardon wear the crown or it’s all
Napoléonic ? Or is there a gem to blame for all of this? What’s next
 




























Wondering how realistic will goals be for the next semester
Most did are not gonna meet goals for the first one
How often does this happen

ridiculous goals imposed by inexperienced leaders. Board and everyone from MS and above are pocketing all the cash. AEs and VS are unhappy here. culture is so toxic is making people want to leave. Let the exodus begin.